These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26363424)

  • 1. Gait analysis in a mouse model resembling Leigh disease.
    de Haas R; Russel FG; Smeitink JA
    Behav Brain Res; 2016 Jan; 296():191-198. PubMed ID: 26363424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.
    van de Wal MAE; Adjobo-Hermans MJW; Keijer J; Schirris TJJ; Homberg JR; Wieckowski MR; Grefte S; van Schothorst EM; van Karnebeek C; Quintana A; Koopman WJH
    Brain; 2022 Mar; 145(1):45-63. PubMed ID: 34849584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal breathing dysfunction in a mouse model of Leigh syndrome.
    Quintana A; Zanella S; Koch H; Kruse SE; Lee D; Ramirez JM; Palmiter RD
    J Clin Invest; 2012 Jul; 122(7):2359-68. PubMed ID: 22653057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome.
    Hanaford AR; Khanna A; James K; Truong V; Liao R; Chen Y; Mulholland M; Kayser EB; Watanabe K; Hsieh ES; Sedensky M; Morgan PG; Kalia V; Sarkar S; Johnson SC
    Neuropathol Appl Neurobiol; 2024 Jun; 50(3):e12977. PubMed ID: 38680020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome.
    Schleifer G; Marutani E; Ferrari M; Sharma R; Skinner O; Goldberger O; Grange RMH; Peneyra K; Malhotra R; Wepler M; Ichinose F; Bloch DB; Mootha VK; Zapol WM
    Am J Physiol Lung Cell Mol Physiol; 2019 Feb; 316(2):L391-L399. PubMed ID: 30520688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial response promotes neurodegeneration in the Ndufs4 KO mouse model of Leigh syndrome.
    Aguilar K; Comes G; Canal C; Quintana A; Sanz E; Hidalgo J
    Glia; 2022 Nov; 70(11):2032-2044. PubMed ID: 35770802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.
    Ferrari M; Jain IH; Goldberger O; Rezoagli E; Thoonen R; Cheng KH; Sosnovik DE; Scherrer-Crosbie M; Mootha VK; Zapol WM
    Proc Natl Acad Sci U S A; 2017 May; 114(21):E4241-E4250. PubMed ID: 28483998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double administration of self-complementary AAV9NDUFS4 prevents Leigh disease in Ndufs4-/- mice.
    Corrà S; Cerutti R; Balmaceda V; Viscomi C; Zeviani M
    Brain; 2022 Oct; 145(10):3405-3414. PubMed ID: 36270002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease.
    Johnson SC; Kayser EB; Bornstein R; Stokes J; Bitto A; Park KY; Pan A; Sun G; Raftery D; Kaeberlein M; Sedensky MM; Morgan PG
    Mol Genet Metab; 2020 Jun; 130(2):118-132. PubMed ID: 32331968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene.
    Leong DW; Komen JC; Hewitt CA; Arnaud E; McKenzie M; Phipson B; Bahlo M; Laskowski A; Kinkel SA; Davey GM; Heath WR; Voss AK; Zahedi RP; Pitt JJ; Chrast R; Sickmann A; Ryan MT; Smyth GK; Thorburn DR; Scott HS
    J Biol Chem; 2012 Jun; 287(24):20652-63. PubMed ID: 22535952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succination is Increased on Select Proteins in the Brainstem of the NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) Knockout Mouse, a Model of Leigh Syndrome.
    Piroli GG; Manuel AM; Clapper AC; Walla MD; Baatz JE; Palmiter RD; Quintana A; Frizzell N
    Mol Cell Proteomics; 2016 Feb; 15(2):445-61. PubMed ID: 26450614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome.
    Bitto A; Grillo AS; Ito TK; Stanaway IB; Nguyen BMG; Ying K; Tung H; Smith K; Tran N; Velikanje G; Urfer SR; Snyder JM; Barton J; Sharma A; Kayser EB; Wang L; Smith DL; Thompson JW; DuBois L; DePaolo W; Kaeberlein M
    Nat Metab; 2023 Jun; 5(6):955-967. PubMed ID: 37365290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia ameliorates brain hyperoxia and NAD
    Grange RMH; Sharma R; Shah H; Reinstadler B; Goldberger O; Cooper MK; Nakagawa A; Miyazaki Y; Hindle AG; Batten AJ; Wojtkiewicz GR; Schleifer G; Bagchi A; Marutani E; Malhotra R; Bloch DB; Ichinose F; Mootha VK; Zapol WM
    Mol Genet Metab; 2021 May; 133(1):83-93. PubMed ID: 33752971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.
    de Haas R; Das D; Garanto A; Renkema HG; Greupink R; van den Broek P; Pertijs J; Collin RWJ; Willems P; Beyrath J; Heerschap A; Russel FG; Smeitink JA
    Sci Rep; 2017 Sep; 7(1):11733. PubMed ID: 28916769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting NAD
    Lee CF; Caudal A; Abell L; Nagana Gowda GA; Tian R
    Sci Rep; 2019 Feb; 9(1):3073. PubMed ID: 30816177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDUFS4 deletion triggers loss of NDUFA12 in Ndufs4
    Adjobo-Hermans MJW; de Haas R; Willems PHGM; Wojtala A; van Emst-de Vries SE; Wagenaars JA; van den Brand M; Rodenburg RJ; Smeitink JAM; Nijtmans LG; Sazanov LA; Wieckowski MR; Koopman WJH
    Biochim Biophys Acta Bioenerg; 2020 Aug; 1861(8):148213. PubMed ID: 32335026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice.
    Frambach SJCM; van de Wal MAE; van den Broek PHH; Smeitink JAM; Russel FGM; de Haas R; Schirris TJJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165727. PubMed ID: 32070771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated susceptibility to exogenous seizure triggers and impaired interneuron excitability in a mouse model of Leigh syndrome epilepsy.
    Manning A; Han V; Stephens A; Wang R; Bush N; Bard M; Ramirez JM; Kalume F
    Neurobiol Dis; 2023 Oct; 187():106288. PubMed ID: 37704057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial complex I deficiency leads to the retardation of early embryonic development in
    Wang M; Huang YP; Wu H; Song K; Wan C; Chi AN; Xiao YM; Zhao XY
    PeerJ; 2017; 5():e3339. PubMed ID: 28533980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial complex III stabilizes complex I in the absence of NDUFS4 to provide partial activity.
    Calvaruso MA; Willems P; van den Brand M; Valsecchi F; Kruse S; Palmiter R; Smeitink J; Nijtmans L
    Hum Mol Genet; 2012 Jan; 21(1):115-20. PubMed ID: 21965299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.